T1	Outcomes 11 51	efficacy of mitomycin C plus doxorubicin
T2	Outcomes 881 895	response rates
T3	Outcomes 1121 1140	total response rate
T4	Outcomes 1216 1236	disease progression.
T5	Outcomes 1241 1258	progression rates
T6	Outcomes 1467 1482	efficacy to BCG
